Vicarious Surgical names Joseph Doherty as board chairman
Get Alerts RBOT Hot Sheet
Join SI Premium – FREE
Vicarious Surgical Inc. (NYSE: RBOT) appointed Joseph Doherty as chairman of its board of directors, the robotics surgery company announced. Doherty has served as a board member since June 2025.
Doherty currently serves as CEO of Worcester City Campus Corporation, a position he has held since January 2025. The not-for-profit corporation supports the University of Massachusetts.
His healthcare industry experience includes serving as president of Scapa Healthcare and sitting on the board of directors of Scapa Group, which trades on the AIM Stock Exchange. He also served as president of Olympus Surgical Technologies America, a subsidiary of Olympus Corporation of the Americas.
Doherty spent 24 years at Johnson & Johnson (NYSE: JNJ) in various roles, ultimately serving as vice president of integration and transformation. He has also served on boards of the Massachusetts Biomedical Initiative, Immertec, and ZATA Pharmaceuticals, and as an advisor to AccuTec and Boardwalk Robotics.
He holds a bachelor's degree in engineering from the United States Military Academy at West Point and an MBA from Nichols College.
"I am honored to serve as chairman at a pivotal moment for Vicarious Surgical," Doherty said in the company's statement.
Stephen From, the company's chief executive officer, said Doherty "brings a wealth of experience and thoughtful leadership that will serve the company well."
Vicarious Surgical, founded in 2014, develops surgical robotics technology for minimally invasive procedures. The Waltham, Massachusetts-based company has received backing from investors including Bill Gates and Khosla Ventures.
You May Also Be Interested In
- MapLight Therapeutics adds two directors to its board
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wave Life Sciences starts Phase 2a obesity trial for WVE-007 drug
Create E-mail Alert Related Categories
Board ChangesRelated Entities
Bill Gates, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share